Your browser doesn't support javascript.
loading
Temporal and geographical variations in survival of children born with congenital anomalies in Europe: A multi-registry cohort study.
Santoro, Michele; Coi, Alessio; Pierini, Anna; Rankin, Judith; Glinianaia, Svetlana V; Tan, Joachim; Reid, Abigail; Garne, Ester; Loane, Maria; Given, Joanne; Aizpurua, Amaia; Astolfi, Gianni; Barisic, Ingeborg; Cavero-Carbonell, Clara; de Walle, Hermien E K; Den Hond, Elly; García-Villodre, Laura; Gatt, Miriam; Gissler, Mika; Jordan, Sue; Khoshnood, Babak; Kiuru-Kuhlefelt, Sonja; Klungsøyr, Kari; Lelong, Nathalie; Lutke, Renée; Mokoroa, Olatz; Nelen, Vera; Neville, Amanda J; Odak, Ljubica; Rissmann, Anke; Scanlon, Ieuan; Urhoj, Stine Kjaer; Wellesley, Diana; Wertelecki, Wladimir; Yevtushok, Lyubov; Morris, Joan K.
Afiliação
  • Santoro M; Unit of Epidemiology of Rare diseases and Congenital anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Coi A; Unit of Epidemiology of Rare diseases and Congenital anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Pierini A; Unit of Epidemiology of Rare diseases and Congenital anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Rankin J; Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
  • Glinianaia SV; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Tan J; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Reid A; Population Health Research Institute, St George's, University of London, London, UK.
  • Garne E; Population Health Research Institute, St George's, University of London, London, UK.
  • Loane M; Paediatric Department, Hospital Lillebaelt, Kolding, Denmark.
  • Given J; Faculty of Life and Health Sciences, Ulster University, Coleraine, UK.
  • Aizpurua A; Faculty of Life and Health Sciences, Ulster University, Coleraine, UK.
  • Astolfi G; Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain.
  • Barisic I; IMER Registry, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
  • Cavero-Carbonell C; Children's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.
  • de Walle HEK; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
  • Den Hond E; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • García-Villodre L; Provincial Institute for Hygiene, Antwerp, Belgium.
  • Gatt M; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
  • Gissler M; Malta Congenital Anomalies Registry, Directorate for Health Information and Research, Pieta, Malta.
  • Jordan S; THL Finnish Institute for Health and Welfare, Information Services Department, Helsinki, Finland.
  • Khoshnood B; Faculty of Medicine, Health & Life Science, Swansea University, Swansea, UK.
  • Kiuru-Kuhlefelt S; Université de Paris, CRESS-Epopé, INSERM, INRA, Paris, France.
  • Klungsøyr K; THL Finnish Institute for Health and Welfare, Information Services Department, Helsinki, Finland.
  • Lelong N; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
  • Lutke R; Division of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway.
  • Mokoroa O; Université de Paris, CRESS-Epopé, INSERM, INRA, Paris, France.
  • Nelen V; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Neville AJ; Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain.
  • Odak L; Provincial Institute for Hygiene, Antwerp, Belgium.
  • Rissmann A; Imer registry Centre for Epidemiology and Clinical Research University of Ferrara and Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.
  • Scanlon I; Children's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.
  • Urhoj SK; Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
  • Wellesley D; Faculty of Medicine, Health & Life Science, Swansea University, Swansea, UK.
  • Wertelecki W; Paediatric Department, Hospital Lillebaelt, Kolding, Denmark.
  • Yevtushok L; Faculty of Medicine, University of Southampton and Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Morris JK; OMNI-Net for Children International Charitable Fund, Rivne, Ukraine.
Paediatr Perinat Epidemiol ; 36(6): 792-803, 2022 11.
Article em En | MEDLINE | ID: mdl-35675091
BACKGROUND: Congenital anomalies are a major cause of perinatal, neonatal and infant mortality. OBJECTIVES: The aim was to investigate temporal changes and geographical variation in survival of children with major congenital anomalies (CA) in different European areas. METHODS: In this population-based linkage cohort study, 17 CA registries members of EUROCAT, the European network for the surveillance of CAs, successfully linked data on 115,219 live births with CAs to mortality records. Registries estimated Kaplan-Meier survival at 28 days and 5 years of age and fitted Cox's proportional hazards models comparing mortality at 1 year and 1-9 years of age for children born during 2005-2014 with those born during 1995-2004. The hazard ratios (HR) from each registry were combined centrally using a random-effects model. The 5-year survival conditional on having survived to 28 days of age was calculated. RESULTS: The overall risk of death by 1 year of age for children born with any major CA in 2005-2014 decreased compared to 1995-2004 (HR 0.68, 95% confidence interval [CI] 0.53, 0.89). Survival at 5 years of age ranged between registries from 97.6% to 87.0%. The lowest survival was observed for the registry of OMNI-Net (Ukraine) (87.0%, 95% CI 86.1, 87.9). CONCLUSIONS: Survival of children with CAs improved for births in 2005-2014 compared with 1995-2004. The use of CA registry data linked to mortality data enables investigation of survival of children with CAs. Factors such as defining major CAs, proportion of terminations of pregnancy for foetal anomaly, source of mortality data and linkage methods are important to consider in the design of future studies and in the interpretation of the results on survival of children with CAs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anormalidades Congênitas / Parto Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Infant / Newborn / Pregnancy País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anormalidades Congênitas / Parto Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Infant / Newborn / Pregnancy País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article